Clinical Trials

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Michelle Senchyna, PhD, of Aerie Pharmaceuticals, provides an update on the company’s ongoing projects.

MediCane Health Inc. announced recruitment of the first patient for its phase 2a study designed to assess the effects of cannabis oil in adults with probable Alzheimer’s disease who have limited or no response to antipsychotic medication.

Salvat Laboratories has submitted a new drug application to the FDA for clobetasol nanoemulsion to treat inflammation and pain after ocular surgery.

Emerging evidence has shown chimeric antigen receptor T-cell therapies are highly effective regardless of a patient’s race or ethnicity.

Theranica Bio-electronics announced positive top-line results from a double-blind, randomized, placebo-controlled, multicenter clinical trial to evaluate efficacy and safety of Nerivio for the treatment of episodic and chronic migraine.

Patients with cancer and obesity appeared well-represented in clinical trials, indicating that clinical trial findings may be generalizable to this patient population, according to study results published in JAMA Network Open.

Fewer than one in six guidelines put forth by the American College of Rheumatology and EULAR are backed up by head-to-head, randomized clinical trials, according to data published in ACR Open Rheumatology.

Adults aged older than 70 years expressed the same level of interest in participating in cancer clinical trials as younger adults, according to study results in a research letter published in JAMA Network Open.

Improving diversity in cancer clinical trial enrollment has become an increased priority among oncology researchers.

Cyclo Therapeutics announced that a phase 2b study for its investigational drug Trappsol Cyclo, which targets the reduction of amyloid beta and tau in the treatment of early Alzheimer’s disease, is now underway.